查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1831920

2025-2033年核醫設備市場報告（按產品、應用、最終用戶和地區）

Nuclear Medicine Equipment Market Report by Product, Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球核醫設備市場規模達33億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到54億美元，2025-2033年期間的複合年成長率（CAGR）為5.56%。由於對慢性病治療和早期診斷的需求日益成長，該市場正在經歷顯著成長。此外，影像技術的創新以及醫療保健領域（尤其是新興和已開發地區在腫瘤學和神經病學應用方面的投資不斷增加）正在進一步擴大市場規模。

核子醫學設備市場趨勢：

混合成像系統的採用日益增多

全球核子設備市場的一個顯著趨勢是，SPECT 和 PET 等混合影像解決方案的應用日益廣泛。根據產業報告，2024 年 2 月，印度 PGIMER 公司開發了一種基於 PET/CT 的尖端活體組織切片技術，前列腺癌診斷的成功率高達 95%。此類先進技術融合了解剖成像和功能成像，提高了心血管疾病和癌症等複雜疾病的診斷精度。此外，此類系統的引入使醫護人員能夠更好地監測病情進展，從而製定更有效的治療策略。此外，這種對混合系統的青睞凸顯了對升級診斷工具日益成長的需求，從而刺激了市場成長，並促進了影像技術的進一步研發活動。

提高分子影像的利用率

根據核醫設備市場研究報告，分子影像在全球市場正迅速發展。這一趨勢主要得益於該技術能夠提供分子和細胞活動的詳細分析，這有助於早期疾病檢測，尤其是在心臟病學、腫瘤學和神經病學領域。此外，分子影像技術能夠實現更準確的診斷，並支持整體的個人化治療方法。例如，2024 年 2 月，北美放射學會的研究人員開發了一種分子影像技術，該技術對乳癌檢測具有高靈敏度，並降低了假陽性結果的可能性，即假陽性率為 16%，而 MRI 為 62%。此外，隨著研究不斷提高此類程序中使用的放射性藥物的效率，對分子成像的需求預計將飆升，使其成為市場中的關鍵趨勢。

放射性藥物的採用率提高。

根據核醫設備市場報告，放射性藥物的廣泛應用是全球市場的主要趨勢之一。放射性藥物在治療和診斷應用中發揮著至關重要的作用，尤其對於某些慢性疾病和癌症。此外，放射性藥物開發的創新，例如降低副作用和增強標靶劑，正在提高核子治療和影像的療效。此外，醫療保健提供者目前依賴此類化合物進行治療和診斷程序，這反過來又推動了對能夠有效利用此類先進藥物的核醫學設備的需求。例如，2024年8月，領先的製藥公司禮來公司（Eli Lily）宣布其在核同位素生產行業的擴張，以確保放射性腫瘤藥物所需的放射性化合物的穩定供應。作為擴張策略，該公司向同位素供應商Ionetix投資了1000萬美元。

核子醫學設備市場細分：

按產品分類：

  • 單光子發射電腦斷層掃描
    • 獨立
    • 雜交種
  • 正子斷層掃描
    • 獨立
    • 雜交種
  • 平面閃爍掃描

單光子發射電腦斷層掃描佔據大部分市場佔有率

根據核醫設備市場預測，單光子發射電腦斷層掃描 (SPECT) 預計將繼續保持其作為最大產品細分市場的主導地位。獨立 SPECT 系統提供必要的功能性影像，廣泛應用於腫瘤學、心臟病學和神經病學。而混合 SPECT 系統融合了功能成像和解剖成像，透過提供更具洞察力的影像來提高診斷精度。此外，混合成像系統的快速應用，尤其是在複雜的診斷條件下，進一步刺激了市場需求。此外，混合 SPECT 系統提供的精確度極大地推動了其在新興和已開發醫療保健市場的採用。例如，2024 年 3 月，Spectrum Dynamics Medical 宣布其全新創新數位 SPECT/CT VERITON-CT 400 已在歐洲一家癌症中心成功安裝。這是一款能夠有效偵測並定位體內腫瘤的混合 SPECT/CT。

按應用分類：

  • 神經病學
  • 腫瘤學
  • 心臟病學
  • 其他

腫瘤學佔產業最大佔有率

根據核醫設備市場概況，腫瘤學佔據主導地位，這主要歸因於癌症治療和診斷對 SPECT 和 PET 等核子造影技術的需求日益成長。這些系統透過精確的分子影像，有助於早期發現癌組織並觀察治療效果。此外，全球癌症發生率的上升，加上放射性藥物和核子醫學的進步，持續推動了對腫瘤專用影像設備的需求，使腫瘤學成為全球核子醫學市場的主要成長領域。根據世界衛生組織的數據，大約五分之一的人在其一生中被診斷出患有癌症，而大約十二分之一的女性和男性死於癌症。

按最終用戶分類：

  • 醫院
  • 影像中心
  • 學術及研究機構
  • 其他

醫院是主要的細分市場

醫院是最大的終端用戶群體，對核醫設備市場收入貢獻巨大。作為一個擁有強大基礎設施以維持先進治療和診斷程序的醫療機構，醫院迅速依賴PET和SPECT等尖端影像技術進行精準治療和診斷。此外，將核醫設備納入醫院生態系統對於提升病患照護水準和預後至關重要，尤其是在神經內科、腫瘤科和心臟科。此外，創新核成像技術的廣泛應用以及對醫院影像中心投資的不斷增加，正在推動這一關鍵市場領域的成長。

按地區分類：

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

北美引領市場，佔據最大核醫設備市場佔有率

該報告還對所有主要區域市場進行了全面分析，包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告指出，北美是核子醫學設備最大的區域市場。

北美已成為領先的區域市場，主要得益於其強大的醫療基礎設施、早期採用尖端技術以及高昂的醫療支出。美國尤其處於領先地位，這主要是因為心血管疾病和癌症等慢性疾病的發生率很高，這大大加速了對核子影像的需求。根據美國國家癌症研究所的數據，預計到2024年，美國將新增2,001,140例癌症病例，約有611,720人將死於癌症。此外，政府對研發的投入，加上主要產業參與者的存在，進一步鞏固了北美在全球核子醫學設備市場的主導地位。

本報告回答的關鍵問題：

  • 全球核子醫學設備市場迄今表現如何，未來幾年將如何表現？
  • 全球核子醫學設備市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球核醫設備市場有何影響？
  • 主要的區域市場有哪些？
  • 哪些國家代表最具吸引力的核醫設備市場？
  • 根據產品，市場是如何分類的？
  • 核子醫學設備市場中最具吸引力的產品是什麼？
  • 根據應用，市場是如何分類的？
  • 核子醫學設備市場中最吸引人的應用是什麼？
  • 根據最終用戶，市場是如何分類的？
  • 核子醫學設備市場中最具吸引力的最終用戶是哪一個？
  • 市場的競爭結構是怎麼樣的？
  • 全球核子醫學設備市場的主要參與者/公司有哪些？

本報告回答的關鍵問題：

  • 全球核子醫學設備市場迄今表現如何，未來幾年將如何表現？
  • 全球核子醫學設備市場的促進因素、限制因素和機會是什麼？
  • 每個促進因素、限制因素和機會對全球核醫設備市場有何影響？
  • 主要的區域市場有哪些？
  • 哪些國家代表最具吸引力的核醫設備市場？
  • 根據產品，市場是如何分類的？
  • 核子醫學設備市場中最具吸引力的產品是什麼？
  • 根據應用，市場是如何分類的？
  • 核子醫學設備市場中最吸引人的應用是什麼？
  • 根據最終用戶，市場是如何分類的？
  • 核子醫學設備市場中最具吸引力的最終用戶是哪一個？
  • 市場的競爭結構是怎麼樣的？
  • 全球核子醫學設備市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球核子醫學設備市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 單光子發射電腦斷層掃描
    • 關鍵部分
      • 獨立
      • 混合
  • 正子斷層掃描
    • 關鍵部分
      • 獨立
      • 混合
  • 平面閃爍掃描

第7章：市場區隔：依應用

  • 神經病學
  • 腫瘤學
  • 心臟病學
  • 其他

第 8 章：市場區隔：依最終用戶

  • 醫院
  • 影像中心
  • 學術及研究機構
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 10 章：SWOT 分析

第 11 章：價值鏈分析

第 12 章：波特五力分析

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Biodex Medical Systems Inc. (Mirion Technologies Inc.)
    • Cardinal Health Inc.
    • CMR Naviscan Corporation
    • DDD-Diagnostic A/S
    • Digirad Corporation
    • General Electric Company
    • Koninklijke Philips NV
    • Mediso Ltd.
    • Neusoft Corporation
    • Siemens AG
    • SurgicEye GmbH
    • Toshiba Corporation
Product Code: SR112025A4598

The global nuclear medicine equipment market size reached USD 3.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.56% during 2025-2033. The market is witnessing significant growth due to the increasing need for chronic diseases treatment and early diagnosis. Moreover, innovations in imaging technologies and heightening investments in healthcare sector, especially in oncology and neurology applications across both emerging and developed region, is further expanding the market.

Nuclear Medicine Equipment Market Trends:

Increasing Adoption of Hybrid Imaging Systems

A notable trend in the global nuclear equipment market is the increasing adoption of hybrid imaging solutions such as SPECT and PET. As per industry reports, in February 2024, PGIMER, India, developed a cutting-edge PET/CT-based biopsy that exhibited 95% success rate for prostate cancer diagnosis. Such advanced technologies blend anatomical and functional imaging, offering improved precision in diagnosing complicated diseases such as cardiovascular disorders and cancer. In addition, the incorporation of such systems allows healthcare professionals to better monitor the progression of disease, resulting in a more efficient treatment strategy. Moreover, this inclination towards hybrid systems highlights the fueling demand for upgraded diagnostics tools, spurring market growth and fostering further research and development activities in imaging techniques.

Increasing Utilization Molecular Imaging

According to the nuclear medicine equipment market research report, molecular imaging is rapidly gaining momentum in the global market. This trend is primarily driven by the technology's capability to offer detailed analysis of molecular as well as cellular activity, which assists in early disease detection, especially in cardiology, oncology, and neurology. In addition, molecular imaging technologies are permitting more accurate diagnoses, supporting the overall customized treatment methods. For instance, in February 2024, researchers from the Radiological Society of North America developed a molecular imaging technology that offers high sensitivity for breast cancer detection with lowered chances of false positive results, i.e. 16% false positive rate in comparison to MRI's 62%. Moreover, as research continues to enhance the efficiency of radiopharmaceuticals leveraged in such procedures, the requirement for molecular imaging is anticipated to soar, establishing it as a critical trend in the market.

Heightened Adoption of Radiopharmaceuticals.

As per the nuclear medicine equipment market report, the amplifying adoption of radiopharmaceuticals is one of the key trends in the global market. Radiopharmaceuticals play a crucial role in therapeutic as well as diagnostic applications, especially for certain chronic disorders and cancer. Moreover, innovations in radiopharmaceutical development, such as lowered side effects and enhanced targeting agents, are improving the efficacy of nuclear therapy and imaging. In addition, healthcare providers are currently dependent of such compounds for treatment as well as diagnosis procedures, which is resultantly boosting the demand for nuclear medicine equipment that are efficient in leveraging such advanced agents. For instance, in August 2024, Eli Lily, a leading pharmaceutical company, announced its expansion in nuclear isotope production industry to secure a steady supply of radioactive compounds requisite for radiopharmaceutical oncology drugs. As an expansion strategy, the company invested USD 10 million into Ionetix, an isotope supplier.

Nuclear Medicine Equipment Market Segmentation:

Breakup by Product:

  • Single-Photon Emission Computed Tomography
    • Standalone
    • Hybrid
  • Positron Emission Tomography
    • Standalone
    • Hybrid
  • Planar Scintigraphy

Single-photon emission computed tomography accounts for the majority of the market share

According to the nuclear medicine equipment market forecast, single-photon emission computed tomography (SPECT) is anticipated to sustain its dominance as the largest product segment. Standalone SPECT systems offer essential functional imaging, broadly leveraged in oncology, cardiology, and neurology. Whereas, hybrid SPECT systems merge both functional and anatomical imaging, providing enhanced diagnostics precision by offering more insightful images. Moreover, the incorporation of hybrid imaging systems in rapidly adopted, especially in complicated diagnostics conditions, further boosting market demand. In addition, the accuracy provided by hybrid SPECT systems is significantly fueling their adoption in emerging as well as developed healthcare markets. For instance, in March 2024, Spectrum Dynamics Medical announced the successful installation of its new, innovative, digital SPECT/CT VERITON-CT 400 at a European cancer center. It is a hybrid SPECT/CT that can efficiently detect and locate tumors in the body.

Breakup by Application:

  • Neurology
  • Oncology
  • Cardiology
  • Others

Oncology holds the largest share of the industry

As per the nuclear medicine equipment market overview, oncology represents the dominant application segment, majorly due to the increasing demand for nuclear imaging technologies such as SPECT and PET in cancer treatment as well as diagnosis. Such systems facilitate the early detection of cancerous tissues and the observation of treatment efficiency through accurate molecular imaging. In addition, the heightening prevalence of cancer worldwide, combined with advancements in radiopharmaceuticals and nuclear medicine, continues to bolster the demand for oncology-specific imaging equipment, establishing oncology as a major growth segment in the global nuclear medicine market. According to the World Health Organization, around 1 in 5 individuals are detected with cancer in their lifetime, while around 1 in 12 women and 1 in men die from this disease.

Breakup by End User:

  • Hospitals
  • Imaging Centers
  • Academic and Research Institutes
  • Others

Hospitals represent the leading market segment

Hospitals are the largest end-user segment that significantly contributes to the nuclear medicine equipment market revenue. As healthcare institutions with the robust infrastructure to maintain the sophisticated therapeutic and diagnostic procedures, hospitals rapidly dependent on cutting-edge imaging technologies such as PET and SPECT for precise treatment as well as diagnosis. In addition, the incorporation of nuclear medicine equipment into hospital ecosystem is requisite for enhancing patient care and outcome, especially in neurology, oncology, and cardiology. Moreover, the magnifying adoption of innovative nuclear imaging technologies and heightening investments in hospital-based imaging centers are bolstering growth within this crucial market segment.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest nuclear medicine equipment market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for nuclear medicine equipment.

North America has emerged as the leading regional market in, majorly driven by its robust healthcare infrastructure, early adoption of cutting-edge technologies and elevated healthcare expenditure. The United States, particularly, is at the forefront chiefly due to the high prevalence of chronic disorders such cardiovascular diseases and cancer, which accelerate the demand for nuclear imaging significantly. According to the National Cancer Institute, it is estimated that in 2024 total 2,001,140 new cancer cases will be diagnosed in the U.S., and around 611,720 individuals will die from this disease. In addition, government funds for research and development, coupled with the presence of key industry players, further fortifies North America's dominance in the global nuclear medicine equipment market.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the nuclear medicine equipment industry include Biodex Medical Systems Inc. (Mirion Technologies Inc.), Cardinal Health Inc., CMR Naviscan Corporation, DDD-Diagnostic A/S, Digirad Corporation, General Electric Company, Koninklijke Philips N.V., Mediso Ltd., Neusoft Corporation, Siemens AG, SurgicEye GmbH, and Toshiba Corporation.
  • The market is represented by fierce competition among key companies such that are currently emphasizing on strategic acquisitions, partnerships, and product innovation, to sustain their market dominance. For instance, in June 2024, QEII Health Sciences Center of Nova Scotia Health acquired GE Healthcare's StarGuide SPECT/CT equipment. This was a USD 6 million project, co-funded by both Nova Scotia and QEII, and improves diagnostic accuracy for heart diseases and cancer. In addition, technological advancements in radiopharmaceutical development and hybrid imaging systems significantly fuel competition, as key players are actively striving to improve their diagnostic precision and enhance patient outcomes. The competitive landscape is further steered by elevating investments in research and technological innovations, consequently contributing to the optimistic nuclear medicine equipment market outlook.

Key Questions Answered in This Report:

  • How has the global nuclear medicine equipment market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global nuclear medicine equipment market?
  • What is the impact of each driver, restraint, and opportunity on the global nuclear medicine equipment market?
  • What are the key regional markets?
  • Which countries represent the most attractive nuclear medicine equipment market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the nuclear medicine equipment market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the nuclear medicine equipment market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the nuclear medicine equipment market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global nuclear medicine equipment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Nuclear Medicine Equipment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Single-Photon Emission Computed Tomography
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Standalone
      • 6.1.2.2 Hybrid
    • 6.1.3 Market Forecast
  • 6.2 Positron Emission Tomography
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Standalone
      • 6.2.2.2 Hybrid
    • 6.2.3 Market Forecast
  • 6.3 Planar Scintigraphy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Neurology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Oncology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cardiology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Imaging Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Academic and Research Institutes
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Biodex Medical Systems Inc. (Mirion Technologies Inc.)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Cardinal Health Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 CMR Naviscan Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 DDD-Diagnostic A/S
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Digirad Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 General Electric Company
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Koninklijke Philips N.V.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Mediso Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Neusoft Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Siemens AG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 SurgicEye GmbH
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Toshiba Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Nuclear Medicine Equipment Market: Major Drivers and Challenges
  • Figure 2: Global: Nuclear Medicine Equipment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Nuclear Medicine Equipment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Nuclear Medicine Equipment Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Nuclear Medicine Equipment Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Nuclear Medicine Equipment Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Nuclear Medicine Equipment Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Nuclear Medicine Equipment (Single-Photon Emission Computed Tomography) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Nuclear Medicine Equipment (Single-Photon Emission Computed Tomography) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Nuclear Medicine Equipment (Positron Emission Tomography) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Nuclear Medicine Equipment (Positron Emission Tomography) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Nuclear Medicine Equipment (Planar Scintigraphy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Nuclear Medicine Equipment (Planar Scintigraphy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Nuclear Medicine Equipment (Neurology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Nuclear Medicine Equipment (Neurology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Nuclear Medicine Equipment (Oncology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Nuclear Medicine Equipment (Oncology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Nuclear Medicine Equipment (Cardiology) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Nuclear Medicine Equipment (Cardiology) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Nuclear Medicine Equipment (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Nuclear Medicine Equipment (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Nuclear Medicine Equipment (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Nuclear Medicine Equipment (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Nuclear Medicine Equipment (Imaging Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Nuclear Medicine Equipment (Imaging Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Nuclear Medicine Equipment (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Nuclear Medicine Equipment (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Nuclear Medicine Equipment (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Nuclear Medicine Equipment (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Nuclear Medicine Equipment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Nuclear Medicine Equipment Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Nuclear Medicine Equipment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Nuclear Medicine Equipment Industry: SWOT Analysis
  • Figure 80: Global: Nuclear Medicine Equipment Industry: Value Chain Analysis
  • Figure 81: Global: Nuclear Medicine Equipment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Nuclear Medicine Equipment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Nuclear Medicine Equipment Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Nuclear Medicine Equipment Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Nuclear Medicine Equipment Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Nuclear Medicine Equipment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Nuclear Medicine Equipment Market: Competitive Structure
  • Table 7: Global: Nuclear Medicine Equipment Market: Key Players